Pooja Lahoti, MD
Family Medicine · Columbus, OHNPI 1750657524
Payments from drug & device makers
Across 155 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$417
- AstraZeneca$408
- AbbVie$345
- Lilly USA, LLC$227
- Bayer$180
- Novo Nordisk$158
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,77099%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 24 | $417 |
| AstraZeneca(2 entities) | 22 | $408 |
| AbbVie | 22 | $345 |
| Lilly USA, LLC | 12 | $227 |
| Bayer | 9 | $180 |
| Novo Nordisk | 10 | $158 |
| Axsome Therapeutics, Inc. | 6 | $128 |
| GSK | 7 | $119 |
| Amgen | 6 | $109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $86 |
| Exact Sciences | 3 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| QOL Medical, LLC | 1 | $30 |
| Merck | 2 | $29 |
| Johnson & Johnson | 2 | $29 |
| Medtronic | 1 | $26 |
| Dexcom, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Biogen | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Vivus LLC | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Neos Therapeutics, LP | 1 | $15 |
| Abbott | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$2,789 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 47 | $56,792 |
| EliquisApixaban | 38 | $42,498 |
| JanuviaSitagliptin Phosphate | 23 | $30,108 |
| OzempicSemaglutide | 17 | $20,633 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $17,324 |
| FarxigaDapagliflozin Propanediol | 11 | $8,473 |
| GemtesaVibegron | 11 | $4,958 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $3,404 |
| Celecoxib | 25 | $2,970 |
| Memantine Hcl | 19 | $2,856 |
| Atorvastatin Calcium | 254 | $2,148 |
| SynthroidLevothyroxine Sodium | 19 | $1,637 |
| Oxycodone Hcl | 17 | $1,444 |
| Duloxetine Hcl | 37 | $1,414 |
| Pantoprazole Sodium | 65 | $1,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $14 | $56,79247 claims |
| PfizerEliquis | $417 | $42,49838 claims |
| MerckJanuvia | $29 | $30,10823 claims |
| Novo NordiskOzempic | $158 | $20,63317 claims |
| GSKTrelegy Ellipta | $119 | $17,32417 claims |
| AstraZenecaFarxiga | $408 | $8,47311 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $20 | $4,95811 claims |
| AbbVieSynthroid | $345 | $1,63719 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $618127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Columbus
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
- Robert FloreaColumbus$955K
- Bryan FeldmanColumbus$404K
- Scott MerrymanColumbus$89K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.